Skip to main content

Enric Trilla Herrera

Currently, I am the Head of the Urology and Kidney Transplant Service. I carry out my work in the area of uro-oncology with special focus on renal tumor pathology, minimally invasive surgery (robotic surgery), and kidney transplantation.

Institutions of which they are part

Head of group
Biomedical Research in Urology
Vall Hebron Institut de Recerca
Head of Department
Urology
General Hospital

Enric Trilla Herrera

Institutions of which they are part

Head of group
Biomedical Research in Urology
Vall Hebron Institut de Recerca
Head of Department
Urology
General Hospital

Currently, I am the Head of the Urology and Kidney Transplant Service. I carry out my work in the area of uro-oncology with special focus on renal tumor pathology, minimally invasive surgery (robotic surgery), and kidney transplantation.

I graduated in Medicine and Surgery from the University of Barcelona in 1994, doing my specialization via MIR at the Bellvitge Hospital.

At the end of it, I joined the Urology Department at Vall d'Hebron Hospital as an assistant physician, where I was Kidney Transplant Coordinator and Clinical Head of the Prostate, Kidney and Transplant Pathology Unit until 2019. I actively participate in numerous research projects in kidney cancer and transplantation within the Renal Pathophysiology Group of VHIR where I am a researcher.

Doctor of Medicine from the University of Barcelona since 2004 and Professor of Surgery (Urology) at the Autonomous University of Barcelona (Teaching Unit of the Vall d'Hebron Hospital).

I am a postgraduate in Clinical Management and Pharmacoeconomics.

I belong to the Spanish Association of Urology, the European Society of Urology (EAU), the Catalan Society of Urology and ASESA.

I have been the author of different articles in both national and international journals and director of several doctoral theses. I also graduated in Art History from the UNED with a specialization in modern art.

Research lines

Markers, prognosis and outcomes of kidney cancer (Clinical research)

One main objective is the discovery of useful markers for detection and prognosis of tumors of the kidney. In addition, we are analysing the outcomes of minimal invasive radio-frequence ablation technique. 

IP: Enric Trilla Herrera

Projects

Immunological reset to overcome alloimmune memory in Highly sensitized patients

IP: Oriol Bestard Matamoros
Collaborators: Ana Pérez González, Francesc Bosch Albareda, Francesc Moreso Mateos, Enric Trilla Herrera, Joana Sellarés Roig, Irina Betsabe Torres Rodriguez, Enric Miret Alomar, Manel Perelló Carrascosa, Nestor Gabriel Toapanta Gaibor, Maria Antonia Emilia Meneghini, Delphine Kervella, Elena Isabel Crespo Gimeno
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 109725
Reference: FMM/ORIOL_BESTARD
Duration: 15/09/2023 - 14/09/2025

KidneyColor: machine learning sobre fotografía digital macroscópica para la predicción de la funcionalidad del trasplante renal de cadáver

IP: Enric Trilla Herrera
Collaborators: -
Funding agency: Asociación Española de Urología
Funding: 25000
Reference: FIU2022/TRILLA
Duration: 29/07/2023 - 28/07/2025

FLUTE: Federate Learning and mUlti-party computation Techniques for prostatE cancer

IP: Olga Méndez Fernández
Collaborators: Berta Miró Cau, Enric Trilla Herrera, Susana Marcos Prieto, Gladys Liliana Lino Villanueva, Lidia del Carmen Ramirez Morales, Ana Sarrias Gimenez
Funding agency: EUROPEAN COMMISSION
Funding: 490375
Reference: FLUTE_HE-HLTH22
Duration: 01/05/2023 - 30/04/2026

Rercerca biomèdica en urologia

IP: Joan Morote Robles
Collaborators: Fernando Lozano Palacio, Inés de Torres Ramirez, Enric Trilla Herrera, Olga Méndez Fernández, Ana Celma Domènech, Mercè Cuadras Solé, Carlos Serrano Burgos, Albert Carrión Puig , Enric Miret Alomar, Maria Eugenia Semidey Raven, Carles Xavier Raventós Busquets, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast, Anna Santamaria Margalef
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00858
Duration: 01/01/2022 - 30/06/2025

Related news

On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.

The work led by Dr. Regis demonstrates that performing robotic reconstruction after radical prostatectomy is associated with better urinary control.

A clinical trial with the prototype of the device shows that the use of this technology improves patient monitoring by nurses and reduces post-surgical complications.

Related professionals

Maria  Larrosa Garcia

Maria Larrosa Garcia

Main researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Sandra  Banderas García

Sandra Banderas García

Ophtalmology
Read more
Gaizka Loyola Sawmillan

Gaizka Loyola Sawmillan

Research technician
Clinical Neuroimmunology
Read more
Nuria Paz Torres Aguila

Nuria Paz Torres Aguila

Predoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.